Sertoli cell tumors of the testis are very rare and are usually benign. Here we report a case of a Sertoli cell tumor of the testis in a 46-year-old man. His chief complaint was a painless, palpable testicular mass that he had for 4 years. Serum levels of tumor markers were within normal limits. Testicular ultrasonography showed a 1.5 cm sized well-demarcated nonhomogeneous echogenic mass in the left testis. Chest x-ray and abdominopelvic CT showed no metastasis. Radical orchiectomy was performed. 
CASE REPORT
A 46-year-old man visited the urology clinic with a complaint of a left scrotal mass. He had discovered a hard mass in his left scrotum 4 years previously but he had not visited the urology clinic because the mass was asymptomatic.
Physical examination revealed a 1.5 cm, well-defined, hard, painless mass. There was no sign of gynecomastia or other feminization. There was no scrotal trauma or other medical problems on his past history.
Serum α-fetoprotein, β-human chorionic gonadotropin, and lactate dehydrogenase were 4.26 IU/ml, 1 mIU/ml, and 397 IU/l, respectively, which were within the normal limits. Serum luteinizing hormone (LH) was slightly elevated (6.22 mIU/ml), but serum follicle stimulating hormone (FSH), prolactin, testosterone, and estradiol were normal. Ultrasonography revealed a 1.5x1.5 cm, well-defined mass with irregular echogenicity in the left testis (Fig. 1) .
We planned to perform either a radical orchiectomy or or- gan-sparing surgery on the basis of the frozen biopsy results.
On gross examination, the mass was 1.7x1.3 cm in size with a white-yellow color and a hard nodular appearance. There was no gross hemorrhage or necrosis in the mass of testis. The specimen was examined quickly by using frozen section analysis. It was proven to be a Sertoli cell tumor, and the patient underwent a radical orchiectomy. Microscopically, the mass was confined in the testicle and there was no invasion to the tunica albuginea or epididymis. The testicular tumor showed a cord of cells with abundant eosinophilic cytoplasm, had prominent centrally located nucleoli, and was surrounded by stromal cells. There was no evidence of malignancy, such as morphological abnormality, necrosis, mitosis, vascular invasion, or solid structure (Fig. 2) . Immunohistochemical staining was positive for vimentin and cytokeratin and focally positive for S-100 but negative for C-kit and SMA (Fig. 3) .
Chest X-ray and abdominopelvic CT scan revealed no evidence of lymphatic or distant metastasis. The patient continues with his follow-up 6 months postoperatively, and no recurrence has been observed. Although metastasis is the only evidence of malignancy in Sertoli cell tumors, there are some reports of late metastasis.
DISCUSSION
The latest metastasis reported in the literature occurred 10 years after radical orchiectomy. 9 Kolon et al 10 suggested that a minimal 5 years of follow-up is necessary because of tumor characteristics.
In our case, we think that the prognosis of our patient will be good because of the small size of the mass, the lack of any histologic abnormalities indicating malignancy, and no evidence of metastasis. But close follow-up will be necessary for detecting late metastasis.
